The TIMERx® oral controlled release
delivery system allows Penwest to modify the release of drugs to provide a therapeutic
benefit to patients by delivering medicines that are more efficacious and provide
greater patient compliance. The technology is cost-effective and easy to scale-up and manufacture.
This sophisticated yet simple delivery technology
precisely and predictably controls drug release and can provide
a range of benefits - reduce dosing frequency, improve drug performance
and compliance, minimize side effects, achieve new indications,
and optimize the performance of chemical entities.
The TIMERx oral drug delivery system achieves a variety
of release profiles (First order, Zero order, BurstCR, etc.) for
a wide range of drugs, accommodating even the most difficult actives.
TIMERx can be used in:
Low to high dose drugs
Insoluble to highly-soluble drugs
Drugs with short half-life and/or narrow therapeutic window
TIMERx enables Penwest to meet the significant challenges of today's pharmaceutical
marketplace head-on with 32 U.S. issued patents and 178 patents worldwide.
|